U.S. Markets closed

The FDA Is Set to Decide on Moderna's Booster. Here's What It Means for the Stock.

·4 min read
The FDA Is Set to Decide on Moderna's Booster. Here's What It Means for the Stock.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Moderna's (NASDAQ: MRNA) stock has seen better days. Shares of the coronavirus vaccine giant have dropped 30% over the past month. Now, investors have turned their attention to something else: A regulatory meeting that could determine whether Moderna's booster candidate reaches the market in the coming days.